landing-hero-images1

ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva

March 23, 2020
Sales and Marketing Cabenuva, Canada, HIV, pharma

ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …

lung_cancer_on_chest_x-ray

AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020
Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …

7424861282_ee152c7c60_b

US continues sanctions against Iran despite coronavirus ravaging both nations

March 23, 2020
Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus

The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …

california_state_flag

Los Angeles County and California State near lockdown after “safer-at-home” mandate is announced

March 20, 2020
Medical Communications Wuhan Coronavirus, china coronavirus, coronavirus

Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home …

gilead-sciences

FDA greenlights Gilead’s Epclusa in hepatitis C patients over six years old

March 20, 2020
Medical Communications, Research and Development Epclusa, Gilead, pharma

Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …

europe-1395916_640

Drug launches across Europe will be affected by coronavirus

March 20, 2020
Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma

The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …

science_nhmrc-grant-annoucement_180824_-_pic_1

New findings on influenza could help improve cancer treatments

March 20, 2020
Manufacturing and Production, Medical Communications Cancer, cancer treatments, flu, flu treatments, influenza

A new study into how the body fights influenza could help improve cancer immunotherapies. Researchers at the Fox Chase Cancer …

astrazeneca_plaque

Japan grants orphan drug designation to Lynparza for BRCA+ unresectable pancreatic cancer

March 19, 2020
Research and Development, Sales and Marketing AstraZeneca, Japan, lynparza, pharma

AstraZeneca has confirmed that its PARP inhibitor Lynparza (olaparib) has been awarded orphan drug designation in Japan for the maintenance …

150130-f-ju830-051

EMA calls on EU to pool resources together to carry out large scale clinical trials against COVID-19

March 19, 2020
Business Services COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

The European Medicines Agency (EMA) has called on the European Union to collaborate closely on carrying out clinical trials on …

Japan approves Novartis’ Zolgensma for spinal muscular atrophy in patients under two years old

March 19, 2020
Sales and Marketing Japan, Novartis, Zolgensma, pharma, spinal muscular atrophy

Novartis has revealed that its gene therapy Zolgensma (onasemnogene abeparvovec) has secured approval from Japan’s Ministry of Health, Labour and …

1200px-coronaviruses_004_lores

COVID-19 can survive in aerosol form and on hard surfaces from hours to days, new study shows

March 19, 2020
Business Services COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus

New research shows that the COVID-19 coronavirus is stable for hours to days in aerosols and on surfaces. This study was …

ibuprofen-400

NICE and EMA to review if Ibuprofen and other anti-inflammatories worsen coronavirus

March 19, 2020
Business Services British Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The National Institute for Health and Care Excellence (NICE) and the European Medicines Regulatory have both stated that there is …

shutterstock_138095450

Global drug spending projected to reach $1.1 trillion by 2024, report argues

March 18, 2020
Research and Development, Sales and Marketing IQVIA, pharma, report

Total global spending on medicines is set to break $1.1 trillion by 2024, a new report released by IQVIA has …

15779565109_e09b063012_b_1

Fujifilm flu drug effective in treating coronavirus in Chinese clinical trials

March 18, 2020
Research and Development COVID-19, Wuhan Coronavirus, coronavirus

A flu drug has appeared to be effective in treating COVID-19, according to recent clinical trials in China. The drug, …

biogen_austria_238

100 coronavirus cases linked to Biogen-hosted event in Boston, State of Massachusetts confirms

March 18, 2020
Manufacturing and Production, Medical Communications, Research and Development Biogen, coronavirus, pharma

It is now known that around 100 of the known cases of the COVID-19 coronavirus can be traced to an …

shutterstock_273326141

$63bn Allergan/AbbVie merger review could be delayed by coronavirus

March 18, 2020
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma

The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory …

gill-leng-380_x_215-1

NICE promotes Professor Gillian Leng as its new Chief Executive

March 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma

NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …

shutterstock_206748499

New technologies and industry collaboration will help fight chronic illnesses

March 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma

Authored by Dan Boot, Head of Digital Innovation at RB Health.Around the world, populations are aging. According to the World …

512px-ursula_von_der_leyen

European Commission offers €80m to CureVac to develop coronavirus vaccine

March 17, 2020
Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus

Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …

The Gateway to Local Adoption Series

Latest content